Related Experiment Video
Updated: Feb 17, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Left atrial dysfunction in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy - A comparative
Dóra Földeák1, Árpád Kormányos2, Péter Domsik2
1Division of Haematology, 2nd Department of Medicine and Cardiology Center, Medical Faculty, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.
Insights
Three-dimensional speckle-tracking echocardiography revealed distinct left atrial (LA) functional patterns in light-chain cardiac amyloidosis (AL-CA) versus hypertrophic cardiomyopathy (HCM). AL-CA showed reduced active atrial emptying and impaired LA strain compared to controls and HCM.
Area of Science:
- Cardiology
- Echocardiography
- Cardiac Imaging
Background:
- Cardiac amyloidosis (CA) involves extracellular fibril deposition.
- Hypertrophic cardiomyopathy (HCM) is characterized by myocyte hypertrophy and fibrosis.
- Distinguishing AL-CA from HCM is crucial for patient management.
Purpose of the Study:
- To compare left atrial (LA) volumetric and functional characteristics between light-chain cardiac amyloidosis (AL-CA) and hypertrophic cardiomyopathy (HCM).
- To utilize three-dimensional speckle-tracking echocardiography (3D-STE) for detailed LA assessment.
Main Methods:
- 16 AL-CA patients, 20 HCM patients, and 16 healthy controls underwent complete 2D Doppler echocardiography and 3D-STE.
- Left atrial volumes and functional parameters were analyzed using 3D-STE.
Main Results:
- Both AL-CA and HCM groups exhibited significantly increased LA volumes compared to controls.
- AL-CA patients showed a significantly reduced active atrial emptying fraction and impaired global/segmental LA strain compared to controls.
- Peak mean segmental longitudinal strain was significantly reduced in HCM patients compared to controls, with AL-CA showing further reductions in certain strain parameters.
Conclusions:
- Three-dimensional speckle-tracking echocardiography reveals distinct patterns of LA functional characteristics in AL-CA and HCM.
- These differences in LA function may aid in differentiating AL-CA from HCM.
Introduction:
While cardiac amyloidosis (CA) is a rare systemic disease characterized by extracellular deposition of protein-derived fibrils, hypertrophic cardiomyopathy (HCM) is histopathologically characterized by myocyte hypertrophy and disarray, interstitial fibrosis, and small intramural coronary arteriole dysplasia. The aim of the present study was to compare left atrial (LA) volumetric and functional characteristics between light-chain (AL) CA and HCM by three-dimensional (3D) speckle-tracking echocardiography (STE).
Methods:
The AL-CA group initially consisted of 17 patients with AL-CA, but one patient was excluded due to inadequate image quality, and so the study population consisted of 16 patients (mean age: 64.0±9.6 years, five men). Their results were compared with data on 20 age-matched HCM patients (mean age: 59.8±5.2 years, 10 men) and on 16 age-matched healthy controls (mean age: 58.2±7.2 years, six men). Complete two-dimensional Doppler echocardiography and 3D-STE were performed in all cases.
Results:
Significantly increased LA volumes were observed in both AL-CA and HCM compared with the control group. Only active atrial emptying fraction was found to be significantly reduced in AL-CA patients compared to controls. Peak global and mean segmental circumferential, longitudinal and area strains showed significant reductions in AL-CA patients compared with controls, but only peak mean segmental longitudinal strain differed significantly between HCM patients and controls. While no differences were demonstrated in global and mean segmental strain at atrial contraction between HCM patients and controls, AL-CA patients showed reductions in certain strain parameters compared to controls and HCM patients.
Conclusions:
Different patterns of LA functional characteristics were demonstrated in AL-CA and HCM patients by 3D-STE.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

